Anti-Human CXCL13 Therapeutic Antibody (MAb 1476)

This antibody that specifically binds to CXCL13 may be used for treating autoimmune or inflammatory diseases, cancers, mucosa-associated lymphoid tissue (MALT) lymphomas, gastric or duodenal ulcers, as well as inhibiting gastric lymphoid follicles.
Supplier Creative Biolabs
Product # TAB-104MZ
Pricing Inquiry
Host Human
Target Homeostatic B Cell-Attracting chemokine 1 (BCA-1, also known as CXCL13, ANGIE, BLC, BLR1L, ANGIE2, or Scybl3)
Species Reactivity Mouse, Cynomolgus monkey
Type Chimeric antibody (mouse/human)
Applications ELISA
Feedback